# IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT

> **NIH NIH N01** · PPD DEVELOPMENT LP · 2022 · $53,713

## Abstract

Administrative support for PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS

## Key facts

- **NIH application ID:** 10658956
- **Project number:** 271201600005I-P00007-27100001-1
- **Recipient organization:** PPD DEVELOPMENT LP
- **Principal Investigator:** MICHAEL GOLD
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $53,713
- **Award type:** —
- **Project period:** 2022-06-30 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10658956

## Citation

> US National Institutes of Health, RePORTER application 10658956, IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT (271201600005I-P00007-27100001-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10658956. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*